Home/Filings/4/0001062993-24-015387
4//SEC Filing

Hippel James 4

Accession 0001062993-24-015387

CIK 0000842023other

Filed

Aug 18, 8:00 PM ET

Accepted

Aug 19, 5:30 PM ET

Size

26.1 KB

Accession

0001062993-24-015387

Insider Transaction Report

Form 4
Period: 2024-08-15
Hippel James
Chief Financial Officer
Transactions
  • Award

    Performance Restricted Stock Units

    2024-08-15+24,06224,062 total
    Common Stock (24,062 underlying)
  • Award

    Restricted Stock Units

    2024-08-15+12,03112,031 total
    Common Stock (12,031 underlying)
  • Award

    Stock Options (Right to Buy)

    2024-08-15+32,41732,417 total
    Exercise: $74.91Exp: 2034-08-15Common Stock (32,417 underlying)
Holdings
  • Stock Options (Right to Buy)

    Exercise: $47.60Exp: 2026-08-07Common Stock (186,068 underlying)
    186,068
  • Common Stock

    99,926
  • Stock Options (Right to Buy)

    Exercise: $31.26Exp: 2024-08-09Common Stock (53,867 underlying)
    53,867
  • Stock Options (Right to Buy)

    Exercise: $44.33Exp: 2025-08-08Common Stock (168,620 underlying)
    168,620
  • Stock Options (Right to Buy)

    Exercise: $66.97Exp: 2027-08-05Common Stock (167,328 underlying)
    167,328
  • Stock Options (Right to Buy)

    Exercise: $120.46Exp: 2028-08-06Common Stock (40,536 underlying)
    40,536
  • Performance Restricted Stock Units

    Common Stock (10,912 underlying)
    10,912
  • Performance Stock Options (Right to Buy)

    Exercise: $94.52Exp: 2029-08-15Common Stock (33,916 underlying)
    33,916
  • Stock Options (Right to Buy)

    Exercise: $94.52Exp: 2029-08-15Common Stock (45,220 underlying)
    45,220
  • Performance Restricted Stock Units

    Common Stock (13,865 underlying)
    13,865
  • Performance Stock Options (Right to Buy)

    Exercise: $84.61Exp: 2030-08-15Common Stock (37,314 underlying)
    37,314
  • Stock Options (Right to Buy)

    Exercise: $84.61Exp: 2030-08-15Common Stock (45,923 underlying)
    45,923
  • Restricted Stock Units

    Common Stock (26,318 underlying)
    26,318
Footnotes (11)
  • [F1]Fully exercisable.
  • [F10]4,010 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 4,011 restricted stock units vest on 8/15/2027.
  • [F11]Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028.
  • [F2]Options to purchase 10,134 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
  • [F4]Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  • [F5]Options to purchase 11,305 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.
  • [F6]Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  • [F7]Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026.
  • [F8]13,159 restricted stock units vest on each of 11/1/2024 and 11/1/2025.
  • [F9]Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Issuer

BIO-TECHNE Corp

CIK 0000842023

Entity typeother

Related Parties

1
  • filerCIK 0001603594

Filing Metadata

Form type
4
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 5:30 PM ET
Size
26.1 KB